Diagnosis: Waldenström’s macroglobulinemia (lymphoplasmacytic lymphoma).

Treatment history: Completed induction chemotherapy.

Current therapy: Rituximab-based immunotherapy in the maintenance phase (subcutaneous, every 2 months).

Current condition: Clinically stable with disease controlled, under routine laboratory monitoring with antiviral and antibiotic prophylaxis.